Ambit Biosciences' Series D - II Round

Ambit Biosciences raised a round of funding on June 21, 2011.

Ambit Biosciences is a biopharmaceutical company engaged in the development of a robust pipeline of small molecule kinase inhibitors for the treatment of cancer, inflammatory disease and other indicat…

Articles about Ambit Biosciences' Series D - II Round: